These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 4604292)

  • 1. Dantrolene sodium in children with spasticity.
    Haslam RH; Walcher JR; Lietman PS; Kallman CH; Mellits ED
    Arch Phys Med Rehabil; 1974 Aug; 55(8):384-8. PubMed ID: 4604292
    [No Abstract]   [Full Text] [Related]  

  • 2. Spasticity and the effect of dantrolene sodium.
    Monster AW
    Arch Phys Med Rehabil; 1974 Aug; 55(8):373-83. PubMed ID: 4605132
    [No Abstract]   [Full Text] [Related]  

  • 3. Dantrolene sodium in athetoid cerebral palsy.
    Chyatte SB; Birdsong JH; Roberson DL
    Arch Phys Med Rehabil; 1973 Aug; 54(8):365-8. PubMed ID: 4578848
    [No Abstract]   [Full Text] [Related]  

  • 4. Dantrolene sodium: long-term effects in severe spasticity.
    Chyatte SB; Basmajian JV
    Arch Phys Med Rehabil; 1973 Jul; 54(7):311-5. PubMed ID: 4577936
    [No Abstract]   [Full Text] [Related]  

  • 5. Dantrolene sodium: long-term effects in patients with muscle spasticity.
    Joynt RL
    Arch Phys Med Rehabil; 1976 May; 57(5):212-7. PubMed ID: 776122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of dantrolene sodium and diazepam in the treatment of spasticity.
    Glass A; Hannah A
    Paraplegia; 1974 Nov; 12(3):170-4. PubMed ID: 4616209
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacology of dantrolene sodium in children.
    Lietman PS; Haslam RH; Walcher JR
    Arch Phys Med Rehabil; 1974 Aug; 55(8):388-92. PubMed ID: 4853611
    [No Abstract]   [Full Text] [Related]  

  • 8. Cooperative study for assessing the effects of a pharmacological agent on spasticity.
    Monster AW; Herman R; Meeks S; McHenry J
    Am J Phys Med; 1973 Aug; 52(4):163-88. PubMed ID: 4722384
    [No Abstract]   [Full Text] [Related]  

  • 9. [Attenuating effect of a new pharmacological agent (Dantrolene sodium) on spasticity].
    Ladd HW; Gingras G; Boucher J; Kazdan N; Keenan R
    Union Med Can; 1973 May; 102(5):1087-92. PubMed ID: 4576244
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of a muscle relaxant: dantrolene sodium (Dantrium).
    Dykes MH
    JAMA; 1975 Feb; 231(8):862-4. PubMed ID: 1089167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myo-relaxant action of sodium Dantrolene in the treatment of tetanus].
    Rocha H
    Rev Inst Med Trop Sao Paulo; 1975; 17(4):257-62. PubMed ID: 1181641
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of spasticity in multiple sclerosis: comparison of dantrolene sodium and diazepam.
    Schmidt RT; Lee RH; Spehlmann R
    Trans Am Neurol Assoc; 1975; 100():235-7. PubMed ID: 1226625
    [No Abstract]   [Full Text] [Related]  

  • 13. Dantrolene sodium for treatment of spasticity.
    Med Lett Drugs Ther; 1974 Jul; 16(15):61-2. PubMed ID: 4843632
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of Dantrium on spasticity in spinal cord injuries.
    Jonsson B; Ladd H; Dahllöf AG
    Scand J Rehabil Med; 1975; 7(2):61-4. PubMed ID: 1162300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of sodium dantroline (Dantrium) in multiple sclerosis (author's transl)].
    Gonsette RE; Capart T; Demonty L
    Acta Neurol Belg; 1978; 78(3):141-7. PubMed ID: 352084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dantrolene sodium: an effective therapeutic agent for the treatment of spasticity in children.
    García-Castro JM
    Bol Asoc Med P R; 1977 Aug; 69(8):263-5. PubMed ID: 334191
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of spasticity with dantrolene sodium.
    Mayer N; Necomber SA; Herman R
    Am J Phys Med; 1973 Feb; 52(1):18-29. PubMed ID: 4685519
    [No Abstract]   [Full Text] [Related]  

  • 18. Spasmolytic properties of dantrolene sodium: clinical evaluation.
    Sheplan L; Ishmael C
    Mil Med; 1975 Jan; 140(1):26-9. PubMed ID: 804674
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical assessment and pharmacologic therapy of spasticity.
    Pedersen E
    Arch Phys Med Rehabil; 1974 Aug; 55(8):344-54. PubMed ID: 4277407
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: Treatment of spasticity in multiple sclerosis with dantrolene.
    Tolosa ES; Soll RW; Loewenson RB
    JAMA; 1975 Sep; 233(10):1046. PubMed ID: 1099254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.